Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy.
PropertyValue
has major subject area list B-Cell Maturation Antigen; Multiple Myeloma
information resource reference Paul B, Rodriguez C, Usmani SZ. BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy. Drugs. 2022 Apr; 82(6):613-631.
label BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy.
Search Criteria
  • Multiple Myeloma